Toward the Broad Adoption of 3D Tumor Models in the Cancer Drug Pipeline
The DOI matches its Crossref record; 146 of the 155 references it cites were found in a registry or an index.
Abstract
Despite a cost of approximately $1 billion to develop a new cancer drug, about 90% of drugs that enter clinical trials fail. A tremendous opportunity exists to streamline the drug selection and testing process, and innovative approaches promise to reduce the burdensome cost of health care for those suffering from cancer. There is great potential for 3D models of human tumors to complement more traditional testing methods; however, the shift from 2D to 3D assays at early stages of the drug discovery and development process is far from widely accepted. 3D platforms range from simple tumor spheroids to more complex microfluidic hydrogels that better mimic the tumor microenvironment. While several companies have developed and patented advanced high-throughput 3D platforms for drug screening, their cost and complexity have limited their adoption as an industry standard. In this review, we will highlight the various tumor platforms that have been developed, emphasizing the approaches that have successfully led to commercial products. We will then consider potential directions toward more relevant tumor models, advantages of the adoption of such platforms within the drug development and screening process, and new opportunities in personalized medicine that such platforms will uniquely enable.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Yet, challenges remain before microfluidic assays can be routinely used in the clinic [82, 83] (Outstanding Question Box) [84].”
From Microfluidics: A New Tool for Modeling Cancer–Immune Interactions (2016) · cites this paper as [82]
Citations
Cites
Lutolf, M. P., & Hubbell, J. A. (2005) · Nature Biotechnology · doi:10.1038/nbt1055 · Cited by 4,551
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Collagen Structure and Stability
Shoulders, M. D., & Raines, R. T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.032207.120833 · Cited by 3,923
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
Hydrogels as extracellular matrix mimics for 3D cell culture
Tibbitt, M. W., & Anseth, K. S. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22361 · Cited by 2,727
Breast cancer metastasis: markers and models
Weigelt, B., Peterse, J. L., & van't Veer, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1670 · Cited by 2,232
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
Research works printed but not linked: 7
- Gevaert M., 2012, Natl. Acad. Eng., 42
- Sutherland R. M., 1971, J. Natl. Cancer Inst., 46, 113
- Zohrabian V. M., 2009, Anticancer Res., 29, 119
- Kosaki R., 1999, Cancer Res., 59, 1141
- Frankel A., 1997, Cancer Res., 57, 2388
- Koutsiaris A. G., 2006, Biorheology, 44, 375
- Takagi A., 2007, Anticancer Res., 27, 45
Cited by
3D tumor spheroids: an overview on the tools and techniques used for their analysis
Costa, E. C., Moreira, A. F., de Melo-Diogo, D., Gaspar, V. M., Carvalho, M. P., & Correia, I. J. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.11.002 · Cited by 929
Design of spherically structured 3D in vitro tumor models -Advances and prospects
Ferreira, L. P., Gaspar, V. M., & Mano, J. F. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.034 · Cited by 249
“tumors, could improve the efficacy of anti-cancer drug discovery and biological performance screening [1].”
BackgroundMicrofluidics: A New Tool for Modeling Cancer–Immune Interactions
Boussommier-Calleja, A., Li, R., Chen, M. B., Wong, S. C., & Kamm, R. D. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2015.12.003 · Cited by 224
“Yet, challenges remain before microfluidic assays can be routinely used in the clinic [82, 83] (Outstanding Question Box) [84].”
MethodLazzari, G., Couvreur, P., & Mura, S. (2017) · Polymer Chemistry · doi:10.1039/c7py00559h · Cited by 200
High-Content Monitoring of Drug Effects in a 3D Spheroid Model
Mittler, F., Obeïd, P., Rulina, A. V., Haguet, V., Gidrol, X., & Balakirev, M. Y. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00293 · Cited by 194
Huang, B.-W., & Gao, J.-Q. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.005 · Cited by 174
3D cancer models: One step closer to in vitro human studies
Manduca, N., Maccafeo, E., Maria, R. D., Sistigu, A., & Musella, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175503 · Cited by 108
Polymeric Biomaterials for In Vitro Cancer Tissue Engineering and Drug Testing Applications
Pradhan, S., Hassani, I., Clary, J. M., & Lipke, E. A. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0567 · Cited by 86
Puls, T. J., Tan, X., Husain, M., Whittington, C. F., Fishel, M. L., & Voytik‐Harbin, S. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-31138-6 · Cited by 93
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Maulana, T. I., Kromidas, E., Wallstabe, L., Cipriano, M., Alb, M., Zaupa, C., Hudecek, M., Fogal, B., & Loskill, P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.015 · Cited by 91
Spheroids in cancer research: Recent advances and opportunities
Arora, S., Singh, S., Mittal, A. K., Desai, N., Khatri, D. K., Gugulothu, D. B., Lather, V., Pandita, D., & Vora, L. K. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106033 · Cited by 91
PEG‐fibrinogen hydrogels for three‐dimensional breast cancer cell culture
Pradhan, S., Hassani, I., Seeto, W. J., & Lipke, E. A. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35899 · Cited by 90
Facile One Step Formation and Screening of Tumor Spheroids Using Droplet‐Microarray Platform
Popova, A. A., Tronser, T., Demir, K., Haitz, P., Kuodyte, K., Starkuviene, V., Wajda, P., & Levkin, P. A. (2019) · Small · doi:10.1002/smll.201901299 · Cited by 84
Bioinstructive microparticles for self-assembly of mesenchymal stem Cell-3D tumor spheroids
Ferreira, L. P., Gaspar, V. M., & Mano, J. F. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.007 · Cited by 74
Shen, Z., Prasai, B., Nakamura, Y., Kobayashi, H., Jackson, M. S., & McCarley, R. L. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01094 · Cited by 72
Chemical Imaging of Platinum-Based Drugs and their Metabolites
Liu, X., & Hummon, A. B. (2016) · Scientific Reports · doi:10.1038/srep38507 · Cited by 69
Anticancer polymers designed for killing dormant prostate cancer cells
Takahashi, H., Yumoto, K., Yasuhara, K., Nadres, E. T., Kikuchi, Y., Buttitta, L., Taichman, R. S., & Kuroda, K. (2019) · Scientific Reports · doi:10.1038/s41598-018-36608-5 · Cited by 63
Application of LDH assay for therapeutic efficacy evaluation of ex vivo tumor models
Cox, M. C., Mendes, R., Silva, F., Mendes, T. F., Zelaya-Lazo, A., Halwachs, K., Purkal, J. J., Isidro, I. A., Félix, A., Boghaert, E. R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97894-0 · Cited by 58
Self-citationKim, H. N., Habbit, N. L., Su, C., Choi, N., Ahn, E. H., Lipke, E. A., & Kim, D. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201807553 · Cited by 57
3D cultures for modeling nanomaterial-based photothermal therapy
Darrigues, E., Nima, Z. A., Griffin, R. J., Anderson, J., Biris, A. S., & Rodriguez, A. (2019) · Nanoscale Horizons · doi:10.1039/c9nh00628a · Cited by 55
Rapid Assessment of Nanoparticle Extravasation in a Microfluidic Tumor Model
Vu, M. N., Rajasekhar, P., Poole, D. P., Khor, S. Y., Truong, N. P., Nowell, C. J., Quinn, J. F., Whittaker, M., Veldhuis, N. A., & Davis, T. P. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b02056 · Cited by 52
Turetta, M., Ben, F. D., Brisotto, G., Biscontin, E., Bulfoni, M., Cesselli, D., Colombatti, A., Scoles, G., Gigli, G., & del Mercato, L. L. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180605122633 · Cited by 50
Sargenti, A., Musmeci, F., Bacchi, F., Delprete, C., Cristaldi, D. A., Cannas, F., Bonetti, S., Pasqua, S., Gazzola, D., Costa, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.564887 · Cited by 49
Ravi, K., Manoharan, T. J. M., Wang, K.-C., Pockaj, B. A., & Nikkhah, M. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122428 · Cited by 46
Going with the Flow: Modeling the Tumor Microenvironment Using Microfluidic Technology
Xie, H., Appelt, J. W., & Jenkins, R. W. (2021) · Cancers · doi:10.3390/cancers13236052 · Cited by 42
Benelli, R., Costa, D., Salvini, L., Tardito, S., Tosetti, F., Villa, F., Zocchi, M. R., & Poggi, A. D. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005660 · Cited by 36
Ascheid, D., Baumann, M., Pinnecker, J., Friedrich, M., Szi-Marton, D., Medved, C., Bundalo, M., Ortmann, V., Öztürk, A., Nandigama, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48010-z · Cited by 37
Organoids, organs-on-chips and other systems, and microbiota
May, S., Evans, S., & Parry, L. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170047 · Cited by 36
Chang, F., Levengood, S. K. L., Cho, N., Chen, L., Wang, E., Yu, J. S., & Zhang, M. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800058 · Cited by 35
Darrigues, E., Nima, Z. A., Nedosekin, D. A., Watanabe, F., Alghazali, K. M., Zharov, V. P., & Biris, A. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-59226-6 · Cited by 33
Cancer drug discovery: recent innovative approaches to tumor modeling
Lovitt, C. J., Shelper, T., & Avery, V. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1214562 · Cited by 31
Rapid Formation of Cell Aggregates and Spheroids Induced by a “Smart” Boronic Acid Copolymer
Amaral, A. J. R., & Pasparakis, G. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b07911 · Cited by 29
Xie, P., Zhao, C., Liang, X., Huang, W., Chen, Y., & Cai, Z. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05812 · Cited by 28
Gangrade, A., & Mandal, B. B. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01043 · Cited by 27
Khafaga, A. F., Mousa, S. A., Aleya, L., & Abdel‐Daim, M. M. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02662-3 · Cited by 27
Bucătariu, S., Constantin, M., Varganici, C., Rusu, D., Nicolescu, A. F., Prisacaru, I., Carnuta, M. G., Anghelache, M., Călin, M., Ascenzi, P., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.10.095 · Cited by 25
Liverani, C., Vita, A. D., Spadazzi, C., Miserocchi, G., Cocchi, C., Bongiovanni, A., Lucia, A. D., Manna, F. L., Fabbri, F., Tebaldi, M., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13037 · Cited by 25
Tan, Q., Xu, L., Zhang, J., Ning, L., Jiang, Y., He, T., Luo, J., Chen, J., Lv, Q., Yang, X., et al. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213301 · Cited by 23
Imidazole-Based pH-Sensitive Convertible Liposomes for Anticancer Drug Delivery
Huang, R., Gyanani, V., Zhao, S. T., Lu, Y., & Guo, X. (2022) · Pharmaceuticals · doi:10.3390/ph15030306 · Cited by 22
Leong, T. K. M., Lo, W. S., Lee, W. E. Z., Tan, B., Lee, X. Z., Lee, L. W. J. N., Lee, J.-Y. J., Suresh, N., Loo, L., Szu, E., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113959 · Cited by 20
Effects of Culture Condition on Epigenomic Profiles of Brain Tumor Cells
Cox, M. C., Deng, C., Naler, L. B., Lu, C., & Verbridge, S. S. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00161 · Cited by 19
Self-citationEnzyme‐Induced Matrix Softening Regulates Hepatocarcinoma Cancer Cell Phenotypes
Liang, Y., Clay, N. E., Sullivan, K. M., Leong, J., Özçelikkale, A., Rich, M. H., Lee, M. K., Lai, M., Hojeong, J., Han, B., et al. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201700117 · Cited by 18
Stamati, K., Redondo, P., Nyga, A., Neves, J. B., Tran, M. G. B., Emberton, M., Cheema, U., & Loizidou, M. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420920597 · Cited by 18
Bess, S. N., Smart, G. K., Igoe, M. J., & Muldoon, T. J. (2024) · In vitro models · doi:10.1007/s44164-024-00074-3 · Cited by 17
Harnessing Tissue Engineering Tools to Interrogate Host-Microbiota Crosstalk in Cancer
Udayasuryan, B., Nguyen, T. T. D., Slade, D. J., & Verbridge, S. S. (2020) · iScience · doi:10.1016/j.isci.2020.101878 · Cited by 16
Self-citationCho, H. J., Verbridge, S. S., Davalos, R. V., & Lee, Y. W. (2018) · Annals of Biomedical Engineering · doi:10.1007/s10439-018-2004-z · Cited by 15
Self-citationGuller, A., Kuschnerus, I. C., Rozova, V. S., Nadort, A., Yao, Y., Khabir, Z., Garcia‐Bennett, A. E., Liang, L., Polikarpova, A., Qian, Y., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111578 · Cited by 15
Mesenchymal Stem Cells Relevance in Multicellular Bioengineered 3D In Vitro Tumor Models
Ferreira, L. P., Gaspar, V. M., Henrique, R., Jerónimo, C., & Mano, J. F. (2017) · Biotechnology Journal · doi:10.1002/biot.201700079 · Cited by 15
Functional biomaterials for biomimetic 3D in vitro tumor microenvironment modeling
Ahmed, T. (2023) · In vitro models · doi:10.1007/s44164-023-00043-2 · Cited by 14
Ugrinic, M., Decanini, D., Bidan, N., Lazzari, G., Harouri, A., Hwang, G., Haghiri‐Gosnet, A., & Mura, S. (2022) · Microelectronic Engineering · doi:10.1016/j.mee.2022.111898 · Cited by 13
Martinez, R., Huang, W., Buck, H., Rea, S., Defnet, A. E., Kane, M. A., & Shapiro, P. (2022) · ACS Omega · doi:10.1021/acsomega.1c05361 · Cited by 12
Hassani, I., Anbiah, B., Kuhlers, P. C., Habbit, N. L., Ahmed, B., Heslin, M. J., Mobley, J. A., Greene, M. W., & Lipke, E. A. (2022) · Biofabrication · doi:10.1088/1758-5090/ac73b6 · Cited by 12
Student, S., Milewska, M., Ostrowski, Z., Gut, K., & Wandzik, I. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111647 · Cited by 10
The impact of impaired DNA mobility on gene electrotransfer efficiency: analysis in 3D model
Meglič, S. H., & Pavlin, M. (2021) · BioMedical Engineering OnLine · doi:10.1186/s12938-021-00922-3 · Cited by 10
Jo, Y., Choi, N., Kim, H. N., & Choi, J. H. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1446970 · Cited by 9
Three-dimensional core-shell alginate microsphere for cancer hypoxia simulation in vitro
Ruan, Y., He, L., Chen, J., Wang, J., Zhao, S., Guo, X., Xie, Y., Cai, Z., Shen, X., & Li, C. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1174206 · Cited by 9
Chen, Z., Han, S., Kim, S., Lee, C., Sanny, A., Tan, A. H., & Park, S. (2023) · The Analyst · doi:10.1039/d3an01904g · Cited by 8
Hydrogels of engineered bacterial fimbriae can finely tune 2D human cell culture
Durá, G., Crespo‐Cuadrado, M., Waller, H., Peters, D. T., Ferreira, A. M., Lakey, J. H., & Fulton, D. A. (2021) · Biomaterials Science · doi:10.1039/d0bm01966f · Cited by 8
Trends in biomaterials for three-dimensional cancer modeling
Caballero, D., Reis, R. L., & Kundu, S. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00001-0 · Cited by 6
Cytotoxic and Radiosensitising Effects of a Novel Thioredoxin Reductase Inhibitor in Brain Cancers
Yao, A., Storr, S. J., Inman, M. W., Barwell, L., Moody, C. J., & Martin, S. G. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02808-4 · Cited by 6
Li, L., & Selaru, F. M. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2022.01.011 · Cited by 6
Krishnamoorthi, S., Kasinathan, G. N., Paramasivam, G., Rath, S. N., & Prakash, J. (2023) · ACS Omega · doi:10.1021/acsomega.3c05617 · Cited by 6
A new approach to assess drug sensitivity in cells for novel drug discovery
Mazzarella, L., & Curigliano, G. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1437136 · Cited by 6
Bioinspired biomaterials to develop cell-rich spherical microtissues for 3D in vitro tumor modeling
Monteiro, M. V., Gaspar, V. M., & Mano, J. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00002-2 · Cited by 5
Darrigues, E., Nima, Z. A., Watanabe, F., & Biris, A. S. (2020) · Nanotechnology · doi:10.1088/1361-6528/abc643 · Cited by 5
Pautu, V., Zhao, H., Mielcarek, A., Balasso, A., Couvreur, P., Serre, C., & Mura, S. (2021) · Biomaterials Science · doi:10.1039/d1bm00669j · Cited by 5
Hollins, A. J., & Parry, L. (2016) · Current Pathobiology Reports · doi:10.1007/s40139-016-0119-1 · Cited by 5
Liu, Y., Johnson, J., Zhang, H., Huang, P., & Li, L. (2025) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-025-05843-x · Cited by 3
Huniadi, M., Nosálová, N., Almášiová, V., Horňáková, Ľ., Valenčáková-Agyagosová, A., Hudáková, N., & Cizkova, D. (2024) · Cells · doi:10.3390/cells13080695 · Cited by 3
Probes and nano-delivery systems targeting NAD(P)H:quinone oxidoreductase 1: a mini-review
Mu, X., Xu, Y., Wang, Z., & Shi, D. (2022) · Frontiers of Chemical Science and Engineering · doi:10.1007/s11705-022-2194-7 · Cited by 3
Microfluidics in Microbiome and Cancer Research
Udayasuryan, B., Slade, D. J., & Verbridge, S. S. (2019) · Wiley eBooks · doi:10.1002/9783527818341.ch9 · Cited by 2
Self-citationLu, Y. (2019) · Scholarly Commons (University of the Pacific) · Cited by 2
Microfluidics and Cancer Treatment: Emerging Concept of Biomedical Engineering
Tawade, P. V., & Tondapurkar, N. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9786-0_15 · Cited by 2
Cox, M. C. (2018) · VTechWorks (Virginia Tech) · Cited by 1
Self-citationHsu, W. (2018) · Nottingham ePrints (University of Nottingham)
Responsive polymers as cell surface modifiers and 3D healable microenvironments
Amaral, M. H., & Jose, A. R. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Gonçalves, A. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/bevg-fk94
midazole-based pH-sensitive Convertible Liposomes for Anticancer Drug Delivery
Huang, R. (2020) · Scholarly Commons (University of the Pacific)
do Amaral, R. L. F. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2020.tde-21092021-055958
Mimicking Chemical Features of the Tumor Microenvironment
Jayaprakash, S. R., Patra, I. P., Bist, S., & Pradhan, S. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166013-00097
Impact of newer technologies in cancer research and its management
Kapoor, R. (2022) · International Journal of Noncommunicable Diseases · doi:10.4103/jncd.jncd_95_22
Targeting thioredoxin system to improve radiotherapeutic response of brain cancers
Yao, A. (2020) · Nottingham ePrints (University of Nottingham)
Metadata
- Authors
- Cox, M. C., Reese, L. M., Bickford, L. R., & Verbridge, S. S.
- Affiliations
- Virginia Tech - Wake Forest University School of Biomedical Engineering & Sciences (US)
- Corresponding author
- Verbridge, Scott S.
- Venue
- ACS Biomaterials Science & Engineering
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-09-11
- Volume
- 1
- Issue
- 10
- Pages
- 877-894
- ISSN
- 2373-9878 (ISSN-L)
- OpenAlex
- W2471940455
- Cited by
- 80
- References
- 155
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 8 · 2022: 11 · 2021: 9 · 2020: 13 · 2019: 8 · 2018: 10 · 2017: 7 · 2016: 9
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Biomaterials Science & Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institute for Critical Technology and Applied Science, Virginia Polytechnic Institute and State University
- College of Engineering, Virginia Polytechnic Institute and State
- National Institute of Biomedical Imaging and Bioengineering (R21EB019123)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- 3D tumor models, anticancer drug discovery, tumor spheroids, tumor microenvironment, high-throughput drug screening, personalized medicine, drug development costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.